184 related articles for article (PubMed ID: 15290005)
1. Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat.
Arguello PA; Jentsch JD
Psychopharmacology (Berl); 2004 Dec; 177(1-2):141-50. PubMed ID: 15290005
[TBL] [Abstract][Full Text] [Related]
2. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Fattore L; Cossu G; Martellotta CM; Fratta W
Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
[TBL] [Abstract][Full Text] [Related]
3. Effects of the CB1R agonist WIN-55,212-2 and the CB1R antagonists SR-141716 and AM-1387: open-field examination in rats.
Järbe TU; Ross T; DiPatrizio NV; Pandarinathan L; Makriyannis A
Pharmacol Biochem Behav; 2006 Sep; 85(1):243-52. PubMed ID: 16996123
[TBL] [Abstract][Full Text] [Related]
4. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
5. Chronic and acute adenosine A
Mouro FM; Batalha VL; Ferreira DG; Coelho JE; Baqi Y; Müller CE; Lopes LV; Ribeiro JA; Sebastião AM
Neuropharmacology; 2017 May; 117():316-327. PubMed ID: 28235548
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid signalling inhibits sarcoplasmic Ca
Oláh T; Bodnár D; Tóth A; Vincze J; Fodor J; Reischl B; Kovács A; Ruzsnavszky O; Dienes B; Szentesi P; Friedrich O; Csernoch L
J Physiol; 2016 Dec; 594(24):7381-7398. PubMed ID: 27641745
[TBL] [Abstract][Full Text] [Related]
7. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
McMahon LR; Koek W
Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
[TBL] [Abstract][Full Text] [Related]
8. WIN 55,212-2 Reverted Pilocarpine-Induced Status Epilepticus Early Changes of the Interaction among 5-HT
Di Maio R; Colangeli R; Di Giovanni G
ACS Chem Neurosci; 2019 Jul; 10(7):3296-3306. PubMed ID: 30912644
[TBL] [Abstract][Full Text] [Related]
9. WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors.
Pamplona FA; Takahashi RN
Neurosci Lett; 2006 Apr 10-17; 397(1-2):88-92. PubMed ID: 16406322
[TBL] [Abstract][Full Text] [Related]
10. CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.
Spano MS; Fattore L; Cossu G; Deiana S; Fadda P; Fratta W
Br J Pharmacol; 2004 Oct; 143(3):343-50. PubMed ID: 15339858
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence.
Mitrirattanakul S; López-Valdés HE; Liang J; Matsuka Y; Mackie K; Faull KF; Spigelman I
Alcohol Clin Exp Res; 2007 May; 31(5):855-67. PubMed ID: 17386072
[TBL] [Abstract][Full Text] [Related]
13. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats.
Pamplona FA; Prediger RD; Pandolfo P; Takahashi RN
Psychopharmacology (Berl); 2006 Nov; 188(4):641-9. PubMed ID: 16947018
[TBL] [Abstract][Full Text] [Related]
14. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood.
Alteba S; Korem N; Akirav I
Learn Mem; 2016 Jul; 23(7):349-58. PubMed ID: 27317195
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine.
Vlachou S; Stamatopoulou F; Nomikos GG; Panagis G
Int J Neuropsychopharmacol; 2008 Nov; 11(7):905-23. PubMed ID: 18377702
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
19. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K
Clin Exp Pharmacol Physiol; 2007; 34(5-6):439-49. PubMed ID: 17439413
[TBL] [Abstract][Full Text] [Related]
20. CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat.
Vlachou S; Nomikos GG; Panagis G
Psychopharmacology (Berl); 2005 May; 179(2):498-508. PubMed ID: 15821959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]